Yidu Tech Celebrates Significant Profit Milestone in FY2026 with Strong Growth and Future Prospects

Yidu Tech's Milestone in AI Healthcare

On July 2, 2026, Yidu Tech (02158.HK), a prominent player in AI healthcare, unveiled its financial performance during its annual results presentation. This fiscal year ending March 31, 2026, marked a pivotal moment as the company celebrated its first full-year profitability. The reported net profit reached an impressive RMB 78.8 million, exceeding the previously estimated profit range of RMB 55 million to RMB 70 million.

The profit attributable to the company’s owners stood at RMB 72.7 million, approximately 30% above the anticipated figures. Revenue also saw a significant boost, increasing by 14.6% year-on-year to RMB 820 million. Adjusted EBITDA soared over 4.6 times to reach RMB 220 million, demonstrating Yidu Tech's strong market presence and operational effectiveness.

One of the most encouraging signs of the company’s performance was the enhancement of quality earnings, with the gross margin improving from 33.5% in the previous year to 36.4%. Furthermore, in the second half of the fiscal year, Yidu Tech achieved positive operating cash flow of RMB 29.3 million, a clear indication of healthy profitability and efficient cash generation.

Yidu Tech's growth trajectory remained strong, marked by a 22.3% year-over-year increase in new orders within its AI for Medical segment and a remarkable 42.0% rise in its AI for Life Sciences segment. These developments solidify the company's foundation for future revenue growth.

During the presentation, Xu Jiming, Co-founder and CEO of Yidu Tech, expressed that FY2026 signifies a transition from long-term capability building to realizing commercial value. With the help of a unified AI foundation, the company is poised to deliver ongoing value to stakeholders, including healthcare providers, pharmaceutical companies, insurers, and patients. Progress in standardizing and productizing hospital products, as well as escalating high-value pharmaceutical contracts, illustrates Yidu Tech's commitment to innovation.

Additionally, the health management business is thriving, as Yidu Tech collaborates with leading hospitals, key specialty sectors, and esteemed clinical experts to expedite the advancement of AI capabilities from project delivery to scalable products.

Feng Xiaoying, Executive Director and CFO, noted that the company's profitability is not a result of transient factors but stems from a meticulously optimized business mix, enhanced gross margins, improved operating efficiency, and scaling operating leverage. The notable return to positive operating cash flow marks a sustainable earnings quality that will aid future endeavors.

The backbone of Yidu Tech’s operations lies in its proprietary healthcare AI infrastructure, YiduCore. This integrated intelligent platform amalgamates several elements such as a data governance platform, disease models, large language model capabilities, and real-world application frameworks. The quantum leap in healthcare technology necessitates precise, reliable, and safe tools to navigate the complexities of patient care, making YiduCore a game-changer in the medical field. By March 31, 2026, YiduCore had effectively processed and analyzed close to 9 billion authorized medical records, establishing a robust foundation for its ongoing competitive advantage.

Operating across three business segments—AI for Medical, AI for Life Sciences, and AI for Care—Yidu Tech exhibited coordinated growth throughout FY2026. The revenue for AI for Medical reached RMB 380 million, bolstered by significant projects in various provinces. The AI for Life Sciences segment contributed RMB 270 million, serving high-caliber clients including top global pharmaceutical companies. Notably, the AI for Care segment outperformed with a splendid revenue growth of 37.6%, illustrating the company's expansion efforts.

Moving forward, Yidu Tech is poised to deepen AI integration within healthcare, intensify its focus on high-value scenarios, and develop scalable solutions to unlock further commercialization opportunities throughout the ecosystem. The company's sustained commitment to enhancing healthcare AI infrastructure will undoubtedly influence its trajectory in this evolving landscape.

As Yidu Tech navigates its newfound profitability, the future appears bright, embodying ambition and innovation, ensuring it remains integral to the healthcare AI domain.